Agenda – Staging

2023 PERT Agenda

See Agenda for Friday, September 22
See Agenda for Saturday, September 23

Wednesday, September 20

7:30am – 12:00pm
Physicians-in-Training Bootcamp

1:00pm – 2:30pm
Annual Business Meeting

2:45pm – 4:00pm
Annual Industry Meeting

Thursday, September 21

8:00am – 8:40am
Welcome & Keynote

8:30am – 9:30am
Epidemiology of PE, Racial and Gender Disparities
Case Presentation
Epidemiology and Worldwide Burden of PE: Insights from Registries
Gender Based Disparities in PE Care
Race Based Disparities in PE Care
Q & A

9:30am – 10:30am
Diagnosis and Risk Stratification

Case Presentation
PE Pathophysiology: What Are We Dealing With?
CT and Other Imaging in the Diagnosis: What’s New
Echo: Where Does it Fit in and What is The Role of POCUS
Risk Stratification: Refining Our Approaches
Q & A 

11:00am – 12:00pm
New Consortium Initiatives: Moving the Needle Forward
Update on PERC/USFDA
PERT Database 2.0
USFDA Perspective on the PE Space
Centers of Excellence in PE Care: Introduction
Q & A

12:00pm – 1:00pm

1:30 – 2:30pm

A. Why, When and How to Start a PERT – Roundtable Discussion

B. Diagnostic Evaluation: Case Based Discussion
Challenges in Risk Stratification:  Role for Gestalt?
Point of Care Echo:  How to do it, What to Look For

C. ICU Considerations
General ICU Care of the Sick PE Patient: How I do it?
Pharmacologic Support: What to Give, When to Give it
Mechanical Circulatory Support: Practical Considerations Discussion

D. Centers of Excellence in PE Care: What You Should Know
Why are COEs Important
Process and Criteria for COE Certification
Value Proposition in Becoming a COE Discussion

Oral Abstract Presentations
Presentation 1
Presentation 2
Presentation 3
Q & A

3:30pm – 4:15pm
Patient Perspective

4:15pm – 5:15pm
PE Game Show

5:15pm – 7:15pm
Posters & Cocktail Reception

Friday, September 22

6:30am – 7:30am
Meet The Experts

The goal of this session is to provide for an intimate, interactive discussion between participants and a multidisciplinary group of experts addressing all aspects of caring for patients with pulmonary embolism. Participants are invited to submit questions targeting PE care including, but not limited to, epidemiology, risk stratification, special populations, treatment modalities, outcomes, metrics, and research. Space is limited!
Additional Cost: $50

8:00am – 8:30am
Welcome Day 2

8:30am – 9:30am
Medical Management: It’s Not Always About Devices!
Case Presentation
Outpatient vs. Inpatient Care
Anticoagulation Options: What are The Data?
Screening for Thrombophilia: Yes, No or Maybe?
Q & A

9:30 – 10:30am
Blackhawk Down: Treating the ‘Big One’
Case Presentation
What is “High Risk”?:  Not Always Clear
MCS:  A Plumbing Lesson
Pro:  Surgical Embolectomy is the Treatment of Choice for High-Risk Patients
Con:  High Risk Patients Should be Treated Non-Surgically
Q & A

11:00am – 12:00pm
The Catheters! What Would I Choose in This Case?
Case Presentation
Catheter Directed Thrombolysis is My Choice
Aspiration Thrombectomy is My Choice
Hybrid Approach is My Choice
On the Horizon in Catheter Technology
Q & A


1:15pm – 2:15pm
Clinical Trials in PE: New Data Coming Soon!
Q & A

2:30pm – 3:30pm

E. Balloon Pulmonary Angioplasty: Tips of the Trade
Selection of Patients for BPA
Procedural Approach
Follow up, When to Stop

F. MCS Workshop
ECMO: Who? What? When? Where?
Percutaneous Right Ventricular Assist Device (RVAD)
Pathophysiology Justification of Mechanical Circulatory Support (MCS)
Ideal Timing of MCS

G. It all Started in The Leg
Post-Thrombotic Syndrome
Inferior Vena Caval Thrombosis
Clot in Transit

3:45pm – 4:45pm
Best Papers of the Year
Presentation 1
Presentation 2
Presentation 3
Q & A

Saturday, September 23

8:00am – 8:10am
Welcome Day 3

8:10am – 9:10am
After the Clot: What Now?
Post-PE Clinic:  Why is it Important, What is Done There?
Post-PE Syndrome: What is it? How Do We Diagnose It?
Periprocedural Considerations
Anticoagulation Duration: Are Predictive Equations Useful?
Q & A

9:10am – 10:10am
CTEPH and CTED: Treatable, Under-diagnosed
Epidemiology of CTEPH and CTED
Diagnostic Approach
Pulmonary Thromboendarterectomy: What Is It? What are the Data?
Balloon Pulmonary Angioplasty: An Option for Some Patients
Medical Therapy for CTEPH/CTED
Q & A

11:30am – 12:30pm
Special Populations
Sickle Cell
Q & A

11:30am – 12:30pm
Great Case! Our Most Notable Saves and Toughest Complications
Case 1
Case 2
Case 3
Case 4
Q & A

Meeting Adjourned